Technical Elements Documentation
    Preparing search index...

    Interface DosimetryAnalysis

    Represents the analysis of radiation doses to individuals and populations.

    RCDO-A1

    const dosimetryAnalysis: DosimetryAnalysis = {
      exposurePathways: ["Inhalation", "Ground Shine", "Cloud Submersion"],
      dcfSource: "ICRP Publication 72",
      shieldingConsiderations: "Shielding factors for residential areas were based on typical building attenuation.",
      occupancyConsiderations: "Time-dependent occupancy factors were used for different land use types.",
      dcfUncertainty: {
        sources: ["Age-dependent variability", "Biokinetic model parameters"],
        assumptions: ["Adult dose coefficients are used for the entire population"],
        alternatives: ["Age-specific dose coefficients for different population groups"]
      },
      dcfParameterUncertaintyCharacterisation: "Log-normal distributions were assumed for DCF parameter uncertainties.",
      receptorTypes: ["Adult", "Child (1 year)", "Infant (3 months)"],
      dosimetryModelsUsed: "Dose calculations were performed using the EPA Federal Guidance Report No. 11 and 12 methodologies.",
      doseAggregationMethod: "Organ doses were calculated for key organs, and effective dose was determined using ICRP Publication 103 weighting factors.",
      radionuclideDecayConsideration: "Radionuclide decay was accounted for during atmospheric transport and dose calculations using half-life data.",
      doseIntegrationPeriods: ["7-day thyroid dose", "50-year committed effective dose"]
    };
    interface DosimetryAnalysis {
        dcfParameterUncertaintyCharacterisation?: string;
        dcfSource: string;
        dcfUncertainty: {
            alternatives: string[];
            assumptions: string[];
            sources: string[];
        };
        doseAggregationMethod?: string;
        doseIntegrationPeriods?: string[];
        dosimetryModelsUsed?: string;
        exposurePathways: string[];
        occupancyConsiderations?: string;
        radionuclideDecayConsideration?: string;
        receptorTypes?: string[];
        shieldingConsiderations?: string;
    }
    Index

    Properties

    dcfParameterUncertaintyCharacterisation? dcfSource dcfUncertainty doseAggregationMethod? doseIntegrationPeriods? dosimetryModelsUsed? exposurePathways occupancyConsiderations? radionuclideDecayConsideration? receptorTypes? shieldingConsiderations?

    Properties

    dcfParameterUncertaintyCharacterisation?: string

    Characterisation of the uncertainty distribution of DCF parameters. Required by RCDO-C2.

    "Log-normal distributions were assumed for DCF parameter uncertainties based on literature."

    RCDO-C2

    dcfSource: string

    The recognized source(s) used for Dose Conversion Factors (DCFs). Required by RCDO-A2.

    "ICRP Publication 72", "Federal Guidance Report No. 11"

    RCDO-A3

    dcfUncertainty: {
        alternatives: string[];
        assumptions: string[];
        sources: string[];
    }

    Sources of model uncertainty, related assumptions, and reasonable alternatives for DCFs. Required by RCDO-A10.

    RCDO-A10: Describes how organ doses are calculated and aggregated to determine effective dose or other relevant dose metrics.

    doseAggregationMethod?: string

    Describes how organ doses are calculated and aggregated to determine effective dose or other relevant dose metrics.

    "Organ doses were calculated for key organs, and effective dose was determined using ICRP Publication 103 weighting factors."

    RCDO-A10

    doseIntegrationPeriods?: string[]

    Specifies the time periods over which doses are integrated.

    ["7-day thyroid dose", "50-year committed effective dose"]

    RCDO-C1

    dosimetryModelsUsed?: string

    The dosimetry models used in the analysis.

    "Dose calculations were performed using the EPA Federal Guidance Report No. 11 and 12 methodologies."

    HLR-RCDO-B

    exposurePathways: string[]

    Identified exposure pathways considered in the analysis. Required by RCDO-A1.

    ["Inhalation", "Ground Shine", "Cloud Submersion"]

    RCDO-A1

    occupancyConsiderations?: string

    Considerations for occupancy factors appropriate for receptor locations and activities. Relevant to RCDO-A3.

    "Occupancy factors were assumed to be 1 for all receptors for simplicity." | "Time-dependent occupancy factors were used for different land use types."
    radionuclideDecayConsideration?: string

    Describes how the dosimetry analysis accounts for the physical and radiological decay of radionuclides.

    "Radionuclide decay was accounted for during atmospheric transport and dose calculations using half-life data."

    HLR-RCDO-C

    receptorTypes?: string[]

    Identifies the age groups or receptor types for which doses are calculated.

    ["Adult", "Teenager", "Child (1 year)", "Infant (3 months)"]

    RCDO-A2

    shieldingConsiderations?: string

    Considerations for shielding factors appropriate for receptor locations and activities. Relevant to RCDO-A3.

    "Shielding factors for residential areas were based on typical building attenuation." | "No shielding factors were applied for conservative estimates."

    Settings

    Member Visibility

    On This Page

    Properties